 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Russell Investments Group Ltd. grew its stake in RxSight, Inc. (NASDAQ:RXST Free Report) by 7.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 74,288 shares of the companys stock after ...

Russell Investments Group Ltd. Has $1.24 Million Stock Holdings in RxSight, Inc. (NASDAQ:RXST)

RxSight, Inc. (NASDAQ:RXST  Get Free Report) Director Bakker Juliet Tammenoms sold 16,208 shares of the stock in a transaction on Friday, August 25th. The stock was sold at an average price of...

Bakker Juliet Tammenoms Sells 16,208 Shares of RxSight, Inc. (NASDAQ:RXST) Stock

ALISO VIEJO, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference. RxSights ...

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

Some RxSight, Inc. ( NASDAQ:RXST ) shareholders may be a little concerned to see that the Independent Director, Juliet...

RxSight Independent Director Juliet Tammenoms Bakker Sells 34% Of Holding

Amid rate hikes by Fed to tame inflation, a risk of deflation looms. The Fed has increased interest rates by 5% in almost one and a half year to mitigate the risk of rising prices. However, there are concerns that the significant rise in interest rate in such a short period of time may lead []Amid ...

3 Medical Device Stocks With Potential to Fight Deflation Risk

RxSight: Poised To Make Waves In Ophthalmic Market

RxSight, Inc. (NASDAQ:RXST  Get Free Report) gapped up before the market opened on Tuesday after Oppenheimer raised their price target on the stock from $29.00 to $34.00. The stock had previously closed at $28.84, but opened at $32.00. Oppenheimer currently has an outperform rating on the ...

RxSight (NASDAQ:RXST) Shares Gap Up  on Analyst Upgrade

Bank of America Securities analyst Craig Bijou reiterated a Buy rating on RxSight (RXST Research Report) yesterday and set a price target of $32.... Bank of America Securities analyst Craig Bijou reiterated a Buy rating on RxSight (RXST  Research...

Bank of America Securities Sticks to Their Buy Rating for RxSight (RXST)

ALISO VIEJO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second quarter 2023 ...

RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023

RxSight (NASDAQ:RXST Get Free Report) had its price objective boosted by Needham & Company LLC from $27.00 to $34.00 in a report issued on Wednesday, FlyOnTheWall reports. Needham & Company LLCs target price points to a potential upside of 9.82% from the stocks previous close. Several other research...

RxSight (NASDAQ:RXST) PT Raised to $34.00 at Needham & Company LLC

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Watchers	140
52-Wk Low	$9.78
52-Wk High	$33.77

Market Cap	$953.47M
Volume (M)	264,382.00
52-Wk High	$33.77
52-Wk Low	$9.78

RXST RxSight Inc

About

Feed

News

Sentiment

Earnings

Fundamentals